These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26787615)
21. Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring. Externbrink A; Eggenreich K; Eder S; Mohr S; Nickisch K; Klein S Eur J Pharm Biopharm; 2017 Jan; 110():1-12. PubMed ID: 27793758 [TBL] [Abstract][Full Text] [Related]
22. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935 [TBL] [Abstract][Full Text] [Related]
23. A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings. Malcolm RK; McCullagh S; Woolfson AD; Catney M; Tallon P Biomaterials; 2002 Sep; 23(17):3589-94. PubMed ID: 12109683 [TBL] [Abstract][Full Text] [Related]
24. Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings. Mc Conville C; Major I; Friend DR; Clark MR; Woolfson AD; Malcolm RK J Biomed Mater Res B Appl Biomater; 2012 May; 100(4):891-5. PubMed ID: 22438332 [TBL] [Abstract][Full Text] [Related]
25. Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses. McKay PF; Mann JF; Pattani A; Kett V; Aldon Y; King D; Malcolm RK; Shattock RJ J Control Release; 2017 Mar; 249():74-83. PubMed ID: 28115243 [TBL] [Abstract][Full Text] [Related]
26. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365 [TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates. Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564 [TBL] [Abstract][Full Text] [Related]
28. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074 [TBL] [Abstract][Full Text] [Related]
29. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. Malcolm K; Woolfson D; Russell J; Tallon P; McAuley L; Craig D J Control Release; 2003 Jun; 90(2):217-25. PubMed ID: 12810304 [TBL] [Abstract][Full Text] [Related]
30. [Preparation and release mechanism of gestodene reservoir-type intravaginal rings]. Li CX; Wang YK; Ning MY Yao Xue Xue Bao; 2014 Mar; 49(3):399-405. PubMed ID: 24961114 [TBL] [Abstract][Full Text] [Related]
31. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets. Zhou X; Wang P; Wang J; Liu Z; Hong X; Xiao Y; Liu P; Hu X Carbohydr Polym; 2016 Dec; 154():1-7. PubMed ID: 27577889 [TBL] [Abstract][Full Text] [Related]
32. Long acting betaxolol ocular inserts based on polymer composite. Gevariya HB; Patel JK Curr Drug Deliv; 2013 Aug; 10(4):384-93. PubMed ID: 23909665 [TBL] [Abstract][Full Text] [Related]
33. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Johnson TJ; Gupta KM; Fabian J; Albright TH; Kiser PF Eur J Pharm Sci; 2010 Feb; 39(4):203-12. PubMed ID: 19958831 [TBL] [Abstract][Full Text] [Related]
34. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques. Murphy DJ; Desjardins D; Boyd P; Dereuddre-Bosquet N; Stimmer L; Caldwell A; Le Grand R; Kelly C; van Roey J; Malcolm RK Int J Pharm; 2018 Oct; 550(1-2):300-308. PubMed ID: 30153490 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeutics. Everaert A; Broeckx G; Fransen E; Ludwig A; Kiekens F; Weyenberg W Int J Pharm; 2015 Mar; 481(1-2):37-46. PubMed ID: 25623490 [TBL] [Abstract][Full Text] [Related]
36. A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid. Okada A; Todo H; Itakura S; Hijikuro I; Sugibayashi K Pharm Res; 2021 Mar; 38(3):503-513. PubMed ID: 33638122 [TBL] [Abstract][Full Text] [Related]
37. Recent work on vaginal rings containing antiviral agents for HIV prevention. Spence P; Bhatia Garg A; Woodsong C; Devin B; Rosenberg Z Curr Opin HIV AIDS; 2015 Jul; 10(4):264-70. PubMed ID: 26049952 [TBL] [Abstract][Full Text] [Related]
38. Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device. Murphy DJ; Boyd P; McCoy CF; Kumar S; Holt JD; Blanda W; Brimer AN; Malcolm RK J Control Release; 2016 Mar; 226():138-47. PubMed ID: 26878974 [TBL] [Abstract][Full Text] [Related]
39. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920 [TBL] [Abstract][Full Text] [Related]
40. Compartmental transport model of microbicide delivery by an intravaginal ring. Geonnotti AR; Katz DF J Pharm Sci; 2010 Aug; 99(8):3514-21. PubMed ID: 20222027 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]